World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
13258
World Ranking
4303
National Ranking
94

Nathalie Rufer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Nathalie Rufer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 129 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Nathalie Rufer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Nathalie Rufer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 49 D-Index — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Nathalie Rufer is affiliated with the University Hospital of Lausanne in Switzerland. Their research focuses primarily on the fields of Medicine and Immunology and Microbiology, with significant contributions across various subfields including Infectious Diseases, Immunology, Oncology, Neurology, and Molecular Biology.

The scientific topics covered in their work span multiple areas of immunological and clinical research, notably:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • CAR-T cell therapy research
  • Long-Term Effects of COVID-19
  • Vaccines and immunoinformatics approaches
  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction

Among their recent publications are the following papers:

  • "Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors" (2023, Nature Communications)
  • "Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients" (2021, Frontiers in Immunology)
  • "Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4 + T cells" (2020, Science Advances)
  • "Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery" (2021, Frontiers in Immunology)
  • "Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell-depleting agents" (2022, British Journal of Haematology)

Nathalie Rufer has collaborated frequently with a range of coauthors. Among the most recurrent are Michaël Hebeisen, Julien Schmidt, Péter Vollenweider, David Gachoud, and David Gfeller.

Their work has been published extensively in numerous scientific venues. The most frequent publication outlets include:

  • Frontiers in Immunology
  • British Journal of Haematology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Science Advances
  • Zenodo (CERN European Organization for Nuclear Research)

Best Publications

  • Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients

    Lukas Baitsch;Petra Baumgaertner;Estelle Devêvre;Sunil K. Raghav

  • Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.

    Hermann Einsele;Eddy Roosnek;Nathalie Rufer;Christian Sinzger

  • Telomere Fluorescence Measurements in Granulocytes and T Lymphocyte Subsets Point to a High Turnover of Hematopoietic Stem Cells and Memory T Cells in Early Childhood

    Nathalie Rufer;Tim H. Brümmendorf;Steen Kolvraa;Claus Bischoff

  • Rapid and strong human CD8 + T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909

    Daniel E. Speiser;Danielle Liénard;Nathalie Rufer;Verena Rubio-Godoy

  • Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry.

    Nathalie Rufer;Wieslawa Dragowska;Gayle Thornbury;Eddy Roosnek

  • Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection

    L Papagno;C A Spina;A Marchant;M Salio

  • Decreased specific CD8+ T cell cross‐reactivity of antigen recognition following vaccination with Melan‐A peptide

    Victor Appay;Victor Appay;Daniel E. Speiser;Nathalie Rufer;Severine Reynard

  • Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.

    Pedro Romero;Alfred Zippelius;Alfred Zippelius;Isabel Kurth;Mikaël J. Pittet;Mikaël J. Pittet

  • Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance

    Alfred Zippelius;Pascal Batard;Verena Rubio-Godoy;Gilles Bioley

  • MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer

    Jan C. Dudda;Bruno Salaun;Yun Ji;Douglas C. Palmer

  • The proteolytic activity of the paracaspase MALT1 is key in T cell activation.

    Fabien Rebeaud;Stephan Hailfinger;Anita Posevitz-Fejfar;Myriam Tapernoux

  • Evidence for a TCR Affinity Threshold Delimiting Maximal CD8 T Cell Function

    Daphné A. Schmid;Melita B. Irving;Vilmos Posevitz;Michael Hebeisen

  • Transfer of the human telomerase reverse transcriptase(TERT) gene into T lymphocytes results in extension of replicative potential

    Nathalie Rufer;Marco Migliaccio;Jennifer Antonchuk;R. Keith Humphries

  • Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization.

    Lukas Baitsch;Amandine Legat;Leticia Barba;Silvia A. Fuertes Marraco

  • Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions.

    Nathalie Rufer;Alfred Zippelius;Pascal Batard;Mikaël J. Pittet

  • Long-lasting stem cell–like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination

    Silvia A. Fuertes Marraco;Silvia A. Fuertes Marraco;Charlotte Soneson;Laurène Cagnon;Philippe O. Gannon

  • Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.

    Pedro Romero;Danila Valmori;Mikael J. Pittet;Alfred Zippelius

  • Thymic selection generates a large T cell pool recognizing a self-peptide in humans.

    Alfred Zippelius;Mikaël J. Pittet;Pascal Batard;Nathalie Rufer

  • High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation.

    Daniel E. Speiser;Jean-Marie Tiercy;Nathalie Rufer;Christophe Grundschober

  • New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site.

    Victor Appay;Camilla Jandus;Verena Voelter;Severine Reynard

  • Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen

    Daniel E. Speiser;Petra Baumgaertner;Verena Voelter;Estelle Devevre

  • Interplay between T Cell Receptor Binding Kinetics and the Level of Cognate Peptide Presented by Major Histocompatibility Complexes Governs CD8+ T Cell Responsiveness

    Melita Irving;Vincent Zoete;Michael Hebeisen;Daphné Schmid

Frequent Co-Authors

Daniel E. Speiser
Daniel E. Speiser University of Lausanne
Pedro Romero
Pedro Romero University of Lausanne
Immanuel F. Luescher
Immanuel F. Luescher University of Lausanne
Jean-Charles Cerottini
Jean-Charles Cerottini University of Lausanne
Olivier Michielin
Olivier Michielin University of Lausanne
Mikael J. Pittet
Mikael J. Pittet University of Geneva
Alfred Zippelius
Alfred Zippelius University Hospital of Basel
Philippe Guillaume
Philippe Guillaume University of Lausanne
Alois Gratwohl
Alois Gratwohl University of Basel
Pierre-Yves Dietrich
Pierre-Yves Dietrich University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related fields like psychiatric nursing and nurse practitioner roles can broaden career opportunities. Many students seek pmhnp programs online with best clinical placement to ensure quality hands-on experience alongside theoretical knowledge, enhancing job readiness after graduation.

Cost is a significant factor when choosing a program. Fortunately, there are several cheap psych np programs that offer accredited education without compromising quality, making advanced nursing degrees more accessible.

Understanding future earnings is equally important. Prospective students should review dnp salary transparency data to make informed decisions about specialization and location, maximizing return on investment after completing a Doctor of Nursing Practice degree.

For nurses aiming to advance, obtaining an acute care nurse practitioner certification can open doors to specialized roles in high-demand clinical settings, aligning well with immunological research and patient care needs.

Best Scientists Citing Nathalie Rufer

Trending Scientists

Recently Published Articles